Eli Lilly to invest $750 million in Ohio injectable drug manufacturing

The expansion with contract manufacturer Resilience will add at least 400 jobs and support KwikPen production as Lilly pushes to meet strong demand for diabetes and obesity medicines.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.